Bank of New York Mellon »

Candel Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $312k 45k 6.93
2024-06-30 $338k 54k 6.20